How many shares of ACAD does BAKER BROS. ADVISORS LP own?

As of 2026-Q2, BAKER BROS. ADVISORS LP holds 42.9M shares of ACAD (ACADIA Pharmaceuticals Inc.).

What is BAKER BROS. ADVISORS LP's ACAD position worth?

As of 2026-Q2, BAKER BROS. ADVISORS LP's ACAD position is worth $1.1B.

In 2026-Q2, BAKER BROS. ADVISORS LP increased their ACAD position (+0.0% change in shares).

Based on available 13F filings, BAKER BROS. ADVISORS LP first reported a position in ACAD in 2019-Q1. They have held the position across 30 quarters.

Position history for BAKER BROS. ADVISORS LP's holdings in ACADIA Pharmaceuticals Inc.

Current Value

$1.1B

Current Shares

42.9M

Total Value Change

+$19.4M

Total Shares Change

+3.2M

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	42.9M	+0.0%	$1.1B	5.4%	$25.30	62
2026-Q1	Unchanged	42.9M	0.0%	$954.9M	5.5%	$22.50	0
2025-Q4	Unchanged	42.9M	0.0%	$1.1B	6.7%	$26.70	0
2025-Q3	Unchanged	42.9M	0.0%	$915.4M	6.6%	$21.32	0
2025-Q2	Increased	42.9M	+0.0%	$925.3M	9.0%	$22.12	62
2025-Q1	Unchanged	42.9M	0.0%	$712.2M	7.9%	$17.07	0
2024-Q4	Unchanged	42.9M	0.0%	$786.8M	8.4%	$16.69	0
2024-Q3	Unchanged	42.9M	0.0%	$659.5M	6.8%	$15.69	0
2024-Q2	Increased	42.9M	+0.0%	$696.8M	8.9%	$16.25	61
2024-Q1	Unchanged	42.9M	0.0%	$792.6M	9.9%	$18.49	0
2023-Q4	Unchanged	42.9M	0.0%	$1.3B	15.3%	$31.31	0
2023-Q3	Unchanged	42.9M	0.0%	$893.3M	5.1%	$20.84	0
2023-Q2	Increased	42.9M	+2.2%	$1B	5.9%	$24.00	63
2023-Q1	Increased	41.9M	+0.0%	$789.3M	4.3%	$18.70	58
2022-Q4	Unchanged	41.9M	0.0%	$667.4M	4.0%	$15.92	0
2022-Q3	Unchanged	41.9M	0.0%	$685.9M	4.5%	$16.14	0
2022-Q2	Increased	41.9M	+0.0%	$590.7M	3.4%	$14.22	58
2022-Q1	Unchanged	41.9M	0.0%	$1B	5.8%	$24.41	0
2021-Q4	Unchanged	41.9M	0.0%	$978.2M	4.8%	$23.54	0
2021-Q3	Unchanged	41.9M	0.0%	$696.1M	3.1%	$16.96	0
2021-Q2	Unchanged	41.9M	0.0%	$1B	4.5%	$24.13	0
2021-Q1	Increased	41.9M	+0.0%	$1.1B	4.7%	$25.71	58
2020-Q4	Unchanged	41.9M	0.0%	$2.2B	8.4%	$53.69	0
2020-Q3	Unchanged	41.9M	0.0%	$1.7B	6.9%	$40.41	0
2020-Q2	Unchanged	41.9M	0.0%	$2B	9.0%	$48.16	0
2020-Q1	Increased	41.9M	+2.6%	$1.8B	10.9%	$41.32	64
2019-Q4	Unchanged	40.9M	0.0%	$1.7B	9.3%	$43.16	0
2019-Q3	Increased	40.9M	+4.0%	$1.5B	10.0%	$36.78	64
2019-Q2	Decreased	39.3M	-1.1%	$1.1B	7.1%	$26.73	0
2019-Q1	New	39.7M	-	$1.1B	6.8%	$26.85	98